Skip to main content
SpringerLink
Log in

Cytokine measurements and interpretation of cytokine assays in human disease

  • Special Article
  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Cytokines are powerful mediator and communication molecules capable of regulating a wide spectrum of biologic functions, including immune responses. Although the role of cytokines in the pathogenesis of human disease is not yet understood, assays for cytokines have become a common feature in research and clinical laboratories. However, numerous pitfalls accompany measurements of cytokine levels in body fluids and of cytokine synthesis or gene expression in tissue. Interpretation of results obtained in cytokine assays, especially those performed with pathologic specimens, is fraught with difficulties. While cytokine assays are clearly of value in monitoring patients treated with recombinant cytokines or receiving anticytokine therapy, the clinical significance of cytokine assays is not yet fully established. In this review, some of the complexities associated with cytokine monitoring are discussed. The crucial importance of understanding cytokine biology for meaningful assay interpretation is emphasized.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Oppenheim JJ, Rossio JL, Gearing AJH (eds): Clinical Applications of Cytokines. Role in Pathogenesis, Diagnosis and Therapy. Cary, NC, Oxford University Press, 1994

    Google Scholar 

  2. Akira S, Hirano T, Taga T, Kishimoto T: Biology of the multifunctional cytokines: IL6 and related molecules (IL1 and TNF). FASEB J 4:2860–2867, 1990

    PubMed  Google Scholar 

  3. Lowenthal JW, MacDonald HR: Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor. J Exp Med 164:1060–1074, 1987

    Google Scholar 

  4. Dinarello CA, Wolff SM: Mechanisms of disease: The role of interleukin 1 in disease. N Engl J Med 328:106–113, 1993

    PubMed  Google Scholar 

  5. Miyajima A, Miyatake S, Schreurs J, De Vries J, Arai N, Yokota T, Arai K-I: Coordinate regulation of immune and inflammatory responses by T cell-derived lymphokines. FASEB J 2:2462–2473, 1988

    PubMed  Google Scholar 

  6. Balkwill FR, Burke F: The cytokine network. Immunol Today 10:299–304, 1989

    PubMed  Google Scholar 

  7. Tracey KJ, Beutler B, Lowry SF, Merriweather J, Wolpe S, Milsark IA, Hariri RJ, Fahey TJ, Zentalla A, Albert JD, Shires GT, Cerami A: Shock and tissue injury induced by recombinant human cachectin. Science 234:470–474, 1986

    PubMed  Google Scholar 

  8. Oswald IP, Gazzinelli RT, Sher A, James SL: IL10 synergizes with IL4 and transforming growth factors to inhibit macrophage cytotoxic activity. J Immunol 148:3578–3582, 1992

    PubMed  Google Scholar 

  9. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, Ricci M, Romagnani S: Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88:345–350, 1991

    Google Scholar 

  10. Romagniani S: Human TH1 and TH2: Doubt no more. Immunol Today 12:256–257, 1991

    PubMed  Google Scholar 

  11. Clerici M, Shearer GM: A TH11TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107–115, 1993

    PubMed  Google Scholar 

  12. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, Shearer GM: Changes in interleukin 2 and interleukin 4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 91:759–765, 1993

    PubMed  Google Scholar 

  13. Maggi E, Mazetti M, Ravina A, Annunziato F, DeCarli M, Piccinni MP, Manetti R, Carbonari M, Pesce AM, Del Prete G, Romagnani S: Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 265:244–248, 1994

    PubMed  Google Scholar 

  14. Graziosi C, Pantaleo G, Gantt KR, Portin J-P, Demarst JF, Cohen OJ, Sekaly RP, Fauci AS: Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265:248–252, 1994

    PubMed  Google Scholar 

  15. Brennan FM: Role of cytokines in experimental arthritis. Clin Exp Immunol 97:1–3, 1994

    Google Scholar 

  16. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JW,et al.: Circulating interleukin 1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79–84, 1990

    PubMed  Google Scholar 

  17. Lane JR, Neumann DA, Lafond-Walker A, Herskowitz A, Rose NR: Role of IL1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol 151:1682–1690, 1993

    PubMed  Google Scholar 

  18. Fisher DJ Jr, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA: Initial evaluation of human recombinant interleukin 1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. The IL1RA Sepsis Syndrome Study Group. Crit Care Med 22:12–21, 1994

    PubMed  Google Scholar 

  19. Ohlsson K, Bjoerk P, Bergenfeldt M, Hageman R, Thompson RC: Interleukin 1 receptor antagonist reduces mortality from endotoxin shock. Nature 348:550–552, 1990

    PubMed  Google Scholar 

  20. Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH: Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764–10768, 1993

    PubMed  Google Scholar 

  21. Borden EC, Sondell PM: Lymphokines and cytokines in cancer treatment. Immunotherapy realized. Cancer 65:800–814, 1990

    PubMed  Google Scholar 

  22. Williams DE: Optimizing the effectiveness of hematopoietic growth factors. J Clin Immunol 14:215–223, 1994

    PubMed  Google Scholar 

  23. Knudsen PJ, Dinarello CA, Strom TB: Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 139:4129–4134, 1987

    PubMed  Google Scholar 

  24. Fanslow WC, Sims JE, Sassenfeld H, Morrissey PJ, Gillis S, Dower SK, Widmer MB: Regulation of alloreactivity in vivo by a soluble form of the interleukin 1 receptor. Science 248:739–742, 1990

    PubMed  Google Scholar 

  25. Lesslauer W, Tabuchi H, Gentz R, Brockhaus M, Schlaeger EJ, Grau G, Piguet PF, Pointaire P, Vassalli P, Loetscher H: Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality. Eur J Immunol 21:2883–2886, 1991

    PubMed  Google Scholar 

  26. Rossio JL, Rager HC, Goundry CS, Crisp EA: Cytokine Testing in Clinical Trial Monitoring.In: Manual of Clinical Laboratory Immunology, Ed. 4, NR Rose, EC DeMarcario, JL Fahey, H Friedman, GM Penn (eds). Washington, DC, ASM, 1992, pp 942–947

    Google Scholar 

  27. May LT, Viguet H, Kenney JS, Ida N, Allison AC, Sehgal PB: High levels of “complexed” interleukin 6 in human blood. J Biol Chem 267:19698–19704, 1992

    PubMed  Google Scholar 

  28. James K: Interactions between cytokines and α2- macroglobulin. Immunol Today 11:163–166, 1990

    PubMed  Google Scholar 

  29. Paciotti GF, Baron D, Licinio J, Tamarkin L, Wong M-L, Gold PW, Altemus ME, Rubinow D: Novel enzyme immunoassays for the detection of the cytokines interleukin 1-α and interleukin 2 in the circulation of normal subjects: 24-hour profiles. Prog Neuroendocrin Immunol 5:21–30, 1992

    Google Scholar 

  30. Bargetzi MJ, Lantz M, Smith CG, Torti FM, Olsson I, Eisenberg SP, Starnes HF Jr: Interleukin 1-β induces interleukin 1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Res 53:4010–4013, 1993

    PubMed  Google Scholar 

  31. Arend WP: IL1 antagonism in inflammatory arthritis. Lancet 341:155–156, 1993

    Google Scholar 

  32. Gallay P, Mach J-P, Carrel S: Characterization and detection of naturally occurring antibodies against IL1-alpha and IL1-beta in normal human plasma. Eur Cytokine Network 2:329–338, 1991

    Google Scholar 

  33. Smith CA, Davis T, Anderson D, Solam L, Beckman MP, Jerzy R, Dower SK, Cosman D, Goodwin RG: A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019–1023, 1991

    Google Scholar 

  34. Moore KW, Viera P, Fiorentino DF, Trounstine MI, Kahn TA, Mosmann TR: Homology of cytokine synthesis inhibitory factor (IL10) to the Epstein-Barr virus gene BCRF1. Science 248:1230–1234, 1990

    PubMed  Google Scholar 

  35. McNair ANB, Kerr IM: Viral inhibition of the interferon system. Pharmacol Ther 56:79–95, 1992

    PubMed  Google Scholar 

  36. Cannon JG, van der Meer JW, Kwiatkowski D, Endres S, Lonnemann G, Burke JF, Dinarello CA: Interleukin 1-beta in human plasma: Optimization of blood collection, plasma extraction, and radioimmunoassay methods. Lymphokine Res 7:457–467, 1988

    PubMed  Google Scholar 

  37. Friberg D, Bryant J, Shannon W, Whiteside TL: In vitro cytokine production by normal human peripheral blood mononuclear cells to measure their immunocompetence and state of activation. Clin Diag Lab Immunol 1:261–268, 1994

    Google Scholar 

  38. Rossi MI, Bonino P, Whiteside TL, Flynn WB, Kuller LH: Determination of cytokine production variability in normal individuals over time. Am Geriatr Soc Suppl 41:1993

  39. Gionchetti P, Campieri M, Belluzzi A, Bertinelli E, Ferretti M, Brignola C, Poggioli G, Miglioli M, Barbara L: Mucosal concentrations of interleukin 1-beta, interleukin 6, interleukin 8 and tumor necrosis factor-alpha in pelvic ileal pouches. Digest Dis Sci 1994

  40. Lewis CE, McCracken D, Ling R, Richards PS, McCarthy SP, McGee JO'D: Cytokine release by single, immunophenotyped human cells: Use of the reverse hemolytic plaque assay. Immunol Rev 119:23–39, 1991

    PubMed  Google Scholar 

  41. Fujii M, Sugamura K, Sano K, Nakai M, Sugita K, Hinuma Y: High-affinity receptor-mediated internalization and degradation of IL2 in human T cells. J Exp Med 163:550–562, 1986

    PubMed  Google Scholar 

  42. Bouche G, Gas N, Prats H, Baldin V, Tauber J-P, Teissie J, Almarick F: Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0-G1 transition. Proc Natl Acad Sci USA 84:6770–6774, 1987

    PubMed  Google Scholar 

  43. Vitolo D, Zerbe T, Kanbour A, Dahl C, Herberman RB, Whiteside TL: Expression of mRNA for cytokines in tumorin-filtrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer. Int J Cancer 51:573–580, 1992

    PubMed  Google Scholar 

  44. Vitolo D, Kanbour A, Johnson JT, Herberman RB, Whiteside TL: In situ hybridization for cytokine gene transcripts in the solid tumor microenvironment. Eur J Cancer 3:371–377, 1993

    Google Scholar 

  45. Thomson AW (ed): The Cytokine Handbook. New York, Academic Press, 1994

    Google Scholar 

  46. Bromley L, McCarthy S, Stickland JE, Lewis CE, McGee JO'D: Non-isotopic in situ detection of mRNA for interleukin 4 in archival human tissue. J Immunol Methods 167:47–54, 1994

    PubMed  Google Scholar 

  47. O'Garra A, Vieira P: Polymerase chain reaction for detection of cytokine gene expression. Curr Opin Immunol 4:211–215, 1992

    PubMed  Google Scholar 

  48. Legoux P, Minty C, Delpechi B, Minty AJ, Shire D: Simultaneous quantitation of cytokine mRNAs in interleukin 1 beta stimulated U373 human astrocytoma cells by a polymerisation chain reaction method involving co-amplification with internal multispecific control. Eur Cytokine Network 3:553–563, 1992

    Google Scholar 

  49. Hopkins SJ, Humphreys M: Bioassay of interleukin 1 in serum and plasma following removal of inhibitory activity with polyethylene glycol. J Immunol Methods 133:127–131, 1990

    PubMed  Google Scholar 

  50. Dinarello CA: ELISA kits based on monoclonal antibodies do not measure total IL1-beta synthesis. J Immunol Methods 148:255–259, 1992

    PubMed  Google Scholar 

  51. Casey LC, Balk RA, Bone RC: Plasma cytokines and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 21:771–778, 1993

    Google Scholar 

  52. Dinarello CA: Interleukin 1 and interleukin 1 antagonism. Blood 72:1627–1652, 1991

    Google Scholar 

  53. Sher A, Gazzinelli RT, Oswald IP, Clerici M, Kullberg M, Pearce EJ, Berzofsky JA, Mosmann TR, James SL, Morse HC, Shearer GM: Role of T cell derived cytokines in the down-regulation of immune response in parasitic and retroviral infection. Immunol Rev 127:183–204, 1992

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pathology and Otolaryngology, University of Pittsburgh School of Medicine and Pittsburgh Cancer Institute, 15213, Pittsburgh, Pennsylvania

    Theresa L. Whiteside

Authors
  1. Theresa L. Whiteside
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Whiteside, T.L. Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol 14, 327–339 (1994). https://doi.org/10.1007/BF01546317

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01546317

Key words

Search

Navigation